Administrative Core 1
Administrative Core 1
批准号:
10683943
负责人:
Michael Davies
金额:
$24.34万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
未结题
起止时间:
2019-07-16 至 2025-05-31
关键词:
AdvocateAppointmentAwardBioinformaticsBiometryClinicalClinical TrialsCollaborationsCommunicationConsensusConsultationsData CommonsDevelopmentDisciplineDiseaseEnsureFundingGoalsInstitutionLeadershipMaintenanceMentorsMinorityMonitorPatient CarePatientsPeer ReviewPoliciesPreparationProcessPublicationsQuality ControlRegulationReportingResearchResearch PersonnelResourcesRoleScheduleScientistSiteSkin CancerUnited States National Institutes of HealthUniversity of Texas M D Anderson Cancer CenterWomancareerdata qualitydata repositorydata sharingdata standardsexperienceflexibilityinterdisciplinary approachlecturesmeetingsmelanomaprogramsquality assurancerecruitsymposium
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Adminstrative Core 1: Project Summary/Abstract
Within the SPORE framework, the Administrative Core (Core 1) will be responsible for incorporating the
diverse scientific disciplines of the SPORE investigators into a highly integrated, interdisciplinary approach
focused on achieving excellence in translational melanoma research towards a significant impact on the care
of patients battling this disease. The primary goal of this group is to assure the successful continued oversight
and coordination of all projects, cores, and developmental and career enhancement programs through expert
guidance in fiscal management, centralized communication, and general administration for all activities. This
core will be led by three outstanding scientists and well-established mentors who currently hold high-level
administrative, research, and/or clinical appointments at MD Anderson and possess decades of combined
leadership experience: Drs. Patrick Hwu, Elizabeth Grimm, and Jeffrey E. Lee.
Specific responsibilities of the Administrative Core include the following:
• Compliance with all institutional, federal, and NIH/NCI regulations and requirements.
• Communication and consultation with the NCI project officer and other NCI staff, including preparation
of all required reports, publications, and other requested communications.
• Monitoring data quality control and assurance activities in conjunction with the Biostatistics and
Bioinformatics Core (Core 3).
• Optimization of clinical trial efforts, including monitoring and enhancing accrual progress of related
SPORE clinical trials, through the Clinical Trials Management Resource (co-directed by Dr. Hwu and
Lee) housed within this Administrative Core.
• Maintenance of fiscal and budgetary responsibilities, including implementing the SPORE flexibility
option as appropriate through ongoing assessments of program progress and justifications for funding
allocations/reallocations.
• Convening all necessary meetings, including the Executive Committee, Internal and External Advisory
Boards (IAB/EAB), scientific meetings, research meetings, lectures, and symposia, including
scheduling, development and distribution of meeting materials, and recording minutes as appropriate.
• Coordination and funding of Patient Advocate activities.
• Establishment and monitoring of policies for recruitment and retention of women and minorities in this
program.
• Coordination with other SPORE sites to initiate and enhance collaborative research efforts, co-sponsor a yearly Skin Cancer conference, and pursue opportunities for high potential Developmental
Research Program (DRP) and Career Enhancement Program (CEP) applications from
collaborating investigators.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Administrative Core 1
-
批准号:10415935
-
项目类别:
-
资助金额:$24.49万
-
财政年份:2019
-
负责人:Michael Davies
-
依托单位:
The University of Texas MD Anderson Cancer Center SPORE in Melanoma
-
批准号:10415934
-
项目类别:
-
资助金额:$205.87万
-
财政年份:2019
-
负责人:Michael Davies
-
依托单位:
The University of Texas MD Anderson Cancer Center SPORE in Melanoma
-
批准号:9978748
-
项目类别:
-
资助金额:$212.8万
-
财政年份:2019
-
负责人:Michael Davies
-
依托单位:
Project 1 Targeting the PI3K Pathway to Overcome Resistance to Immunotherapy in Melanomas with Loss of PTEN
-
批准号:10208808
-
项目类别:
-
资助金额:$38.73万
-
财政年份:2019
-
负责人:Michael Davies
-
依托单位:
The University of Texas MD Anderson Cancer Center SPORE in Melanoma
-
批准号:10208804
-
项目类别:
-
资助金额:$194.39万
-
财政年份:2019
-
负责人:Michael Davies
-
依托单位:
The University of Texas MD Anderson Cancer Center SPORE in Melanoma
-
批准号:10683940
-
项目类别:
-
资助金额:$207.04万
-
财政年份:2019
-
负责人:Michael Davies
-
依托单位:
Project 1 Targeting the PI3K Pathway to Overcome Resistance to Immunotherapy in Melanomas with Loss of PTEN
-
批准号:10683948
-
项目类别:
-
资助金额:$41.25万
-
财政年份:2019
-
负责人:Michael Davies
-
依托单位:
Project 1 Targeting the PI3K Pathway to Overcome Resistance to Immunotherapy in Melanomas with Loss of PTEN
-
批准号:10415938
-
项目类别:
-
资助金额:$41.5万
-
财政年份:2019
-
负责人:Michael Davies
-
依托单位:
Rational approaches to melanoma therapy
-
批准号:10013137
-
项目类别:
-
资助金额:$140.04万
-
财政年份:2017
-
负责人:Michael Davies
-
依托单位:
Rational approaches to melanoma therapy
-
批准号:10681839
-
项目类别:
-
资助金额:$58.97万
-
财政年份:2017
-
负责人:Michael Davies
-
依托单位:
Research Project 2 - Targeting Melanoma Tumor Survival and Apoptotic Machinery
-
批准号:10681845
-
项目类别:
-
资助金额:$12.97万
-
财政年份:2017
-
负责人:Michael Davies
-
依托单位:
Research Project 2 - Targeting Melanoma Tumor Survival and Apoptotic Machinery
-
批准号:10013152
-
项目类别:
-
资助金额:$30.8万
-
财政年份:2017
-
负责人:Michael Davies
-
依托单位:
Rational approaches to melanoma therapy
-
批准号:9985257
-
项目类别:
-
资助金额:$143.09万
-
财政年份:2017
-
负责人:Michael Davies
-
依托单位:
Rational Approaches to Melanoma Therapy
-
批准号:10733192
-
项目类别:
-
资助金额:$63.55万
-
财政年份:2017
-
负责人:Michael Davies
-
依托单位:
Rational approaches to melanoma therapy
-
批准号:10251033
-
项目类别:
-
资助金额:$139.18万
-
财政年份:2017
-
负责人:Michael Davies
-
依托单位:
Research Project 2 - Targeting Melanoma Tumor Survival and Apoptotic Machinery
-
批准号:10251044
-
项目类别:
-
资助金额:$30.8万
-
财政年份:2017
-
负责人:Michael Davies
-
依托单位:
Research Project 2 - Targeting Melanoma Tumor Survival and Apoptotic Machinery
-
批准号:9446227
-
项目类别:
-
资助金额:$64.52万
-
财政年份:2017
-
负责人:Michael Davies
-
依托单位:
Rational approaches to melanoma therapy (PDXNet Administrative Supplement to R01CA241148)
-
批准号:10371682
-
项目类别:
-
资助金额:$12.0万
-
财政年份:2017
-
负责人:Michael Davies
-
依托单位:
Rational approaches to melanoma therapy (PDXNet Administrative Supplement to R01CA121118)
-
批准号:10371684
-
项目类别:
-
资助金额:$12.0万
-
财政年份:2017
-
负责人:Michael Davies
-
依托单位:
Personalized targeting of anti-apoptosis pathways to overcome therapeutic resistance in melanoma
-
批准号:10733197
-
项目类别:
-
资助金额:$13.03万
-
财政年份:2017
-
负责人:Michael Davies
-
依托单位:
海外基金